Topical makes the most sense for: Facial skin texture, fine lines, hydration Scalp application for localized hair growth Scar treatment or post-procedure recovery on a specific area Patients who want to fold GHK-Cu into an existing skincare routine Injectable makes the most sense for: Systemic wound healing (especially internal or in areas you can't easily apply cream) Joint and connective tissue support (topical simply can't penetrate deep enough) Broader anti-aging goals beyond the skin surface Patients already running other injectable peptide protocols (CJC-1295/ipamorelin, BPC-157, TB-500) Here's the thing: for joints specifically, there's no argument
Favorable 3% Mixed 97% Unfavorable overall 0% Most reported benefits Benefits users selected when logging a favorable or mixed check-in
POLtheta processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells
found three equine cathelicidins in myeloid cells from bone marrow, termed eCATH-1 (equine cathelicidin-1), eCATH-2, and eCATH-3 [35]
Everything was as described and met my expectations
Microbiology 2004, 150, 14471456
